Antiviral activity of the EB peptide against zoonotic poxviruses

Identification of the Minimal Active Sequence of an Anti-Influenza Virus Peptide

(2011) Jeremy C. Jones et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Virucidal EB Peptide Protects Host Cells from Herpes Simplex Virus Type 1 Infection in the Presence of Serum Albumin and Aggregates Proteins in a Detergent-Like Manner

(2010) H. Bultmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

(2010) A. W. Rimoin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of a Newly Identified 35-Amino-Acid Component of the Vaccinia Virus Entry/Fusion Complex Conserved in All Chordopoxviruses

(2009) P. S. Satheshkumar et al.   JOURNAL OF VIROLOGY

Zoonotic poxviruses

(2009) Sandra Essbauer et al.   VETERINARY MICROBIOLOGY

Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide

(2009) S.E. Altmann et al.   VIROLOGY

The Vaccinia Virus Gene I2L Encodes a Membrane Protein with an Essential Role in Virion Entry

(2008) R. J. Nichols et al.   JOURNAL OF VIROLOGY

Vaccinia Virus L1 Protein Is Required for Cell Entry and Membrane Fusion

(2008) H. Bisht et al.   JOURNAL OF VIROLOGY